34 0


This expertise provides the insights needed to see and act on the opportunities, challenges, and solutions to ensure a successful commercial effort while improving the patient experience. Founded in 2000 in Louisville, Colorado, GHX is a software-as-a-service company that is reducing the cost of doing business in healthcare by automating supply chain processes and improving visibility into the products used in patient care. Today, the company is expanding its solutions to further enhance data management and allow integration of clinical and business systems. Access Healthcare provides business process outsourcing, applications services, and robotic process automation tools to hospitals, health systems, providers, payers, and related service providers.

PopHealth integrates with a healthcare provider’s electronic health record system to produce clinical quality measures on the provider’s patient population. In its most basic form, as in the example of Dropbox and Box, you could choose to focus on consumer or business buyers. Within the consumer and business groups, there are numerous ways to customize an existing solution or business model to a specific group of buyers. Notice how even within the healthcare and blogging groups, there is still room for deeper segmentation.

Imagine slashing the cost of rocket production by a factor of 10, through the use of 3D printing. Acknowledging that the most expensive resource in building rockets is human labor, the founders of Relativity Space – both aerospace engineers – decided that taking humans off of the factory floor would dramatically slash the price of building a rocket. With $8 million in funding and a larger than life mission, Relativity Space has produced an entirely automated rocket production floor, driven by 3D printing and 20 feet tall robotic arms.

In March 2021, the company announced that it had acquired Across Health, a leading global omnichannel engagement consultancy. The combination of its expertise and proprietary Navigator365 product suite—on which more than 40 pharmaceutical companies rely for omnichannel planning and resource allocation—puts Precision Value & Health in a good spot. Looking forward, the company is well-positioned to step into a new level of evidence-based customer engagement that will only lead to greater success for its clients around the globe.

The PR industry has adopted technology at a snail’s pace compared to the rest of the marketing ecosystem. Propel, a recently launched AI-driven CRM for PR, is on a mission to help the PR industry innovate. By collecting loads of data and leveraging wisdom of the crowd, Propel enables PR teams – either agency or in-house – to understand which journalists are relevant, which pitches are resonating, and which campaigns are working. Propel offers actionable insights to help users hone in on the right messages and reporters, and improve quality and quantity of coverage.

Flo has harnessed the power of AI to develop and refine their signature offering in order to deliver personalized medical insights into issues traditionally underserved by mainstream medical professionals such as menstruation, conception, pregnancy, and menopause. MedGenome has been bringing about the future of genomic medicine since it was started in 2013. Having been awarded the coveted MedTech Breakthrough dpc us big techtimes award for its biomedical research in 2018, it has gone on to forge partnerships with 500 hospitals in India and launch the GenomeAsia 100K project to better understand the genetic resources and diversity of our world. Shortly after its launch, Huffington’s leadership carried the company to lists of top startups by Inc. and LinkedIn, and in 2021 it was placed on Forbes’ “America’s Best Startup Employers” list.

Medallia offers its platform to hospitality, retail, financial services, high-tech and B2B companies. Medallia, which is based in Silicon Valley and has raised $255 million in funding, says it has 98% customer retention. The company provides integrated, cloud-based practice and clinical software for specialties of all sizes, from large physician practices to medical billing professionals across the United States. Xoran Technologies’ product line consists of the MiniCAT™ in-office CT scanner, the xCAT® ENT mobile intraoperative CT scanner, and XoranConnect®, a web-based medical image viewing and archival tool. All of the company’s products were designed to eliminate waste and inefficiency in healthcare.

There may be no more powerful discipline for achieving greater outcomes in healthcare than genetic research, and that’s exactly what Delaware company MedGenome is all about. The company’s Next Generation Sequencing facility provides one-of-a-kind insights into the use of epigenetics, CRISPR, and spatial transcriptomics. A leader in the development and advancement of at-home, direct-to-patient healthcare solutions, New York telehealth company Ro has long been dedicated to breaking down barriers between people and providers. Ro features a vertically integrated platform that empowers individuals to follow a complete path to total health, from diagnosis to treatment, all while avoiding the expensive and difficult ins and outs of dealing with health insurance.

Nauto collects information through bidirectional cameras – one facing the road and one facing the driver – which is fed to an AI engine that improves safety. By understanding driver behavior, the company is able to offer insights and education to battle driver distraction and tiredness. In addition to improving safety today, Nauto’s sheer volume of data collection means it may become a powerful player in making autonomous driving a widespread reality. The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2022. This year’s list comprises a wide array of some of the most accomplished executives in the healthcare technology industry…

Intarcia Therapeutics is a biopharmaceutical company developing therapies for chronic diseases. It was founded in California in 1995 under the name BioMedicines—a name that it maintained until 2004, when company leaders decided to change it to its present form. Later, in 2013, the company went bicoastal by relocating its headquarters to Boston, while keeping its manufacturing facility in Hayward, California. Today, on top of Boston and Hayward, Intarcia also has a physical location in the Research Triangle Park, North Carolina, where it continues to work on discovering and developing peptides for its drug delivery system.